North American Immunohematology Market revenue to cross $1.1 Bn by 2028

Published Date: 2022-11-21

Request a sample

North American Immunohematology Market size is estimated to reach USD 1.1 billion by 2028, according to a latest forecast report by Graphical Research.

The rising prevalence of blood disorders and the aging population will impact the future growth of the industry. Due to the rise in blood illnesses like anemia, HIV, and a few types of cancer, the market is anticipated to witness considerable developments throughout the course of the forecast period. Smoking and tobacco use in the region will have a significant influence on the industry as it increases the risk of diseases among people.

In the United States, a large number of youth and the young generation are indulging in tobacco use. For instance, in 2021, nearly 4 out of 10 middle school students and 13 out of 100 high school students reported the use of tobacco products. Smoking and other tobacco products affect the hematological parameters in the body like white blood cell count, hematocrit, hemoglobin, red blood cells count, and corpuscular volume.

The reagents segment will exceed USD 720 million by 2028. The continuous surge in use of reagents for blood testing in hospitals and diagnostic centers is expected to influence the market expansion.

Recently, PerkinElmer’s Oxford Immunotec received FDA approval for its T-Cell Select reagent kit that allows a more automated workflow of its TB test. It is designed to reduce the time taken by labs and their overall costs. The blood sample stability along with the improved blood sample logistics is an attractive feature of the product. Improved and advanced reagent kits in the industry are expected to contribute to the market outlook.

With regards to the technology used, the gel cards segment is anticipated to see tremendous growth during the forecast timeframe. Gel cards have many advantages as compared to alternatives such as saline tubes, as they are more sensitive, less time consuming, fully recordable, and more stable for longer periods.

Browse detailed statistical insights from the report, “North America Immunohematology Market Forecast 2028 By Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Erythrocyte-magnetized technology (EMT)), By Product (Analyzers, Reagents), By End Use (Hospitals, Diagnostic Laboratories, Blood Banks), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

From a regional viewpoint, Canada immunohematology industry size will witness 4% CAGR through 2028. Every year the spending on healthcare facilities in the country is increasing, which will create significant opportunities for analyzers and reagent providers. The gradual surge in geriatric population will contribute to hematological disorders prevailing in the country. Several initiatives are being taken by companies and the government to provide access to healthcare to all citizens.

For example, myHSA, an employee benefits platform, and Dialogue Health Technologies Inc., premium wellness and virtual care platform, have partnered. This tie-up is expected to provide virtual healthcare across the rural and urban regions of the country through a tailor-made application.

The immunohematology in North American market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:

North America Market, By Product

  • Analyzers
  • Reagents

North America Market, By Technology

  • Biochips
  • Gel cards
  • Microplates
  • PCR
  • Erythrocyte-magnetized technology

North America Market, By End-use

  • Hospitals
  • Diagnostic laboratories
  • Blood banks

The above information has been provided for the following countries:

  • North America
    • U.S.
    • Canada